87276 Infectious agent antigen detection by immunofluorescent technique; influenza A virus

Name of the Procedure:

Infectious Agent Antigen Detection by Immunofluorescent Technique; Influenza A Virus

Summary

This procedure uses a specialized technique to detect the presence of Influenza A virus antigens in a patient's sample. It involves applying antibodies that bind to the virus and emit fluorescent light, making the virus visible under a microscope.

Purpose

The procedure is used to diagnose infections caused by the Influenza A virus. Early and accurate detection helps in managing the disease effectively and preventing its spread.

Indications

• Symptoms such as fever, cough, sore throat, body aches, and fatigue suggestive of influenza.
• Exposure to a confirmed case of Influenza A.
• Patients with weakened immune systems or underlying health conditions who are at higher risk of complications from the flu.

Preparation

• No special preparation is usually required.
• Patients may need to provide a respiratory sample, usually a nasal or throat swab.
• Inform the healthcare provider about any medications being taken.

Procedure Description

1. A swab is taken from the patient's nose or throat to collect samples.
2. The sample is treated with antibodies specific to the Influenza A virus.
3. These antibodies are tagged with a fluorescent dye.
4. If the virus is present, the antibodies will bind to it and fluoresce under a microscope.
5. The laboratory specialist examines the sample for the presence of fluorescence, indicating a positive result.

Tools and Equipment:

• Nasal or throat swabs.
• Fluorescently tagged antibodies.
• Fluorescence microscope.

No anesthesia or sedation is required for this procedure.

Duration

The procedure typically takes a few hours to process and analyze the sample in the laboratory. Sample collection takes only a few minutes.

Setting

• Outpatient clinic
• Hospital laboratory

Personnel

• Nurse or medical technician for sample collection.
• Laboratory technician or pathologist for processing and analysis.

Risks and Complications

• Minimal risk involved with sample collection, such as mild discomfort or gag reflex.
• False negatives or positives due to improper sample collection or handling.

Benefits

• Quick and accurate diagnosis of Influenza A virus infection.
• Helps in timely administration of antiviral medications.
• Reduces the spread of the virus by confirming infectious cases.

Recovery

• No recovery time required post sample collection.
• Follow-up may be necessary depending on the results and physician's advice.

Alternatives

• Rapid influenza diagnostic tests (RIDTs)
• Polymerase chain reaction (PCR) tests
• Viral cultures Each alternative varies in terms of accuracy, speed, and cost.

Patient Experience

• Slight discomfort during sample collection.
• No significant pain associated with the procedure.
• Patients can return to normal activities immediately after the sample is taken.